✦ LIBER ✦

Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens

✍ Scribed by Jacqueline E. Calvano; Elisa B. Rush; Lee K. Tan; Paul Peter Rosen; Patrick I. Borgen; Kimberly J. Van Zee

Publisher: Springer
Year: 1997
Tongue: English
Weight: 1021 KB
Volume: 4
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02305555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the CDKN2A ( p16INK4a ) gen

Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas

✍ Rajiv Kumar; Barbro Lundh Rozell; Jari Louhelainen; Kari Hemminki 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 152 KB 👁 1 views

Homozygous deletions of the CDKN2/p16 ge

Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas

✍ Yasuhiro Ono; Keisuke Ueki; J. T. Joseph; D. N. Louis 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 48 KB

Low frequency of p16/CDKN2 gene mutation

Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas

✍ Asunción Esteve; Ghyslaine Martel-Planche; Bakary S. Sylla; Monica Hollstein; Pi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 515 KB

Mutational analysis of the pl6ICDKN2 gene was conducted by direct sequencing of the whole coding sequence (exom 1-3 and flanking splicing sites) in 21 esophageal squamous-cell carcinomas and 3 adenocarcinomas from a high-incidence area of Italy. Two inactivating mutations were found in exon I of the

Association of CDKN2A (p16)/CDKN2B (p15)

Association of CDKN2A (p16)/CDKN2B (p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma

✍ Kunihiro Hamada; Takashi Kohno; Masashi Kawanishi; Susumu Ohwada; Jun Yokota 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

To elucidate the possibility of the existence of multiple tumor suppressor genes on chromosome arm 9p, we performed genetic and epigenetic analyses of the CDKN2A/p16/MTS1 and CDKN2B/p15/MTS2 genes as well as homozygous deletion mapping of 9p in human lung carcinoma. To avoid overlooking genetic alte

Deletional, mutational, and methylation

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer

✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Frequency of mutation and deletion of th

Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population

✍ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).